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Abstract: The emergence of antibiotic resistance and viruses with high epidemic potential made
unexplored marine environments an appealing target source for new metabolites. Marine fungi
represent one of the most suitable sources for the discovery of new compounds. Thus, the aim of
this work was (i) to isolate and identify fungi associated with the Atlantic sponge Grantia compressa;
(ii) to study the fungal metabolites by applying the OSMAC approach (one strain; many compounds);
(iii) to test fungal compounds for their antimicrobial activities. Twenty-one fungal strains (17 taxa)
were isolated from G. compressa. The OSMAC approach revealed an astonishing metabolic diversity
in the marine fungus Eurotium chevalieri MUT 2316, from which 10 compounds were extracted,
isolated, and characterized. All metabolites were tested against viruses and bacteria (reference and
multidrug-resistant strains). Dihydroauroglaucin completely inhibited the replication of influenza A
virus; as for herpes simplex virus 1, total inhibition of replication was observed for both physcion
and neoechinulin D. Six out of 10 compounds were active against Gram-positive bacteria with
isodihydroauroglaucin being the most promising compound (minimal inhibitory concentration (MIC)
4–64 µg/mL) with bactericidal activity. Overall, G. compressa proved to be an outstanding source
of fungal diversity. Marine fungi were capable of producing different metabolites; in particular,
the compounds isolated from E. chevalieri showed promising bioactivity against well-known and
emerging pathogens.
Keywords: sponges; marine fungi; biodiversity; Eurotium chevalieri; OSMAC; bioactive compounds;
antibacterial; antiviral
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1. Introduction
In the last few decades, antibiotic resistance significantly increased, while the discovery of
new molecules suitable for the therapy of infectious diseases slowed down [1]; therefore, finding
new antimicrobial compounds became a priority. Natural products of terrestrial origins are always
considered the primary sources of bioactive molecules [2]. However, unexplored environments and
organisms, such as those inhabiting the sea, became appealing for the discovery of new compounds.
The number of new compounds of marine origin is remarkably high, e.g., in 2016 alone, 1277 new
natural products with promising biomedical applications were described. In this regard, marine
fungi were responsible for producing 36% of these newly described compounds [3]. With regard
to ease of production of compounds of interest, fungi are attractive sources of natural products
when compared to macroorganisms. As an example, large quantities (1000 kg, wet weight) of the
tunicate Ecteinascidia turbinata were necessary to obtain 1 g of trabectedin, a promising anticancer
compound [4]; today, its production is only feasible by bacterial fermentation to obtain a precursor
of trabectedin [5]. On the contrary, many marine fungi can be easily cultivated to achieve a high
yield of secondary metabolites, thus representing a sustainable alternative to chemical synthesis [4].
To expand the range of secondary metabolites produced by marine fungi, the OSMAC (one strain;
many compounds) approach [6], based on the modulation of culture conditions, is widely recognized
as an effective strategy to find new compounds [2,7–11]. Indeed, one way to find new metabolites
is the simulation of the native environment of the marine fungi, including their interactions with
other microorganisms [8,12,13]. However, the extent to which the OSMAC approach induces the
stimulation of secondary metabolites is still the subject of discussion. Experimental data highlighted
that both the modulation of culture conditions and the screening of different fungal species contribute
to increasing the rate of discovery of new metabolites [11]. Thus, marine fungi represent a large
reservoir of uncharacterized natural products to which the OSMAC approach is barely applied [8].
Furthermore, they are one of the lesser studied groups of microorganisms, with only 1206 obligate and
facultative marine species characterized out of the 10,000 estimated [14,15]; however, their biodiversity
is suggested as being much higher [16].
Marine sponges, sometimes referred to as microbial fermenters, are an outstanding source of
highly diverse microbial communities [17], including new fungal species [18]. Several sponge-derived
fungi produced compounds with different biological activities, including anticancer, anti-inflammatory,
and anti-feeding properties for marine organisms [19].
The aim of this study was to (i) investigate for the first time the culturable fungal community
associated with the Atlantic sponge Grantia compressa (Grantiidae, Leucosolenida); (ii) induce
metabolite production by applying the OSMAC approach; (iii) characterize the promising marine
sponge-associated fungus Eurotium chevalieri MUT 2316; and (iv) assess the antimicrobial potential of
the isolated metabolites.
Overall, the OSMAC approach highlighted the fungal strains that produced different secondary
metabolites and the media that were more suitable to increase chemical diversity. Among the marine
fungi isolated, E. chevalieri MUT 2316 was further studied and yielded 10 compounds with promising
antibacterial and antiviral activities, some of which are also present in E. chevalieri KUFA 0006 [20].
2. Materials and Methods
2.1. Sample Materials and Fungal Isolation
Three specimens of the Atlantic sponge G. compressa (identified by Prof G. P. McCormack, NUI,
Ireland) were collected at Coranroo (West Coast of Ireland; WGS84 north (N) 53◦09’100”, west (W)
009◦00’550”) at a site with rapid water flow over limestone rocks. The samples were kept at 4 ◦C
until laboratory analyses were performed. To remove contaminants and sediments, the samples were
surface sterilized with ethanol 70% (30 s) and serially washed in artificial sterile sea water (SW; sea
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salts 30 g, Sigma-Aldrich, Saint Louis, USA, up to 1 L of deionized (DI) H2O). For fungal isolation, two
different techniques were applied, as follows:
(1) Homogenization (HO): 5 g of each sponge sample was homogenized (homogenizer blade
Sterilmixer II, PBI International) in SW (1:10 w/v). One milliliter of the suspension was plated onto
Petri dishes (15 cm Ø) containing (i) Corn Meal Agar SW (CMASW; corn meal 2 g, agar 15 g, sea salts
30 g, Sigma-Aldrich, Saint Louis, USA, up to 1 L of DI H2O); (ii) Malt Extract Agar (MEA; malt 20 g,
glucose 20 g, peptone 2 g, agar 15 g, Sigma-Aldrich, Saint Louis, USA, up to 1 L of DI H2O); or (iii)
Gelatin Agar SW (GASW; gelatin 20 g, sea salts 30 g, agar 15 g, Sigma-Aldrich, Saint Louis, USA, up to
1 L of DI H2O) to mimic sponge composition. Plates were incubated in the dark at 15 ◦C and 25 ◦C,
and checked daily for three weeks. Five replicates for each condition were performed.
(2) Direct plating (DP): sponges were cut into 20 pieces (about 0.5 cm3) and plated onto Petri
dishes (6 cm Ø) containing CMASW or SW Agar (SWA; sea salts 30 g, agar 15 g, Sigma-Aldrich,
Saint Louis, USA, up to 1 L of DI H2O). Plates were incubated in the dark at 15 ◦C and 25 ◦C, and
checked daily for three weeks. Five replicates for each condition were performed.
All media were supplemented with an antibiotic mix (gentamicin sulfate 40 mg/L, piperacillin
plus tazobactam 11 mg/L) to avoid bacterial growth.
2.2. Fungal Identification
Fungi were identified by both their morpho-physiological features [21–23] and molecular data.
Briefly, fungal specimens were firstly identified to genus level based on their morphology in order to use
the most appropriate primers for molecular analysis. Subsequently, the genomic DNA was extracted
using a NucleoSpin kit (Macherey Nagel GmbH, Duren, DE, USA), according to the manufacturer’s
instructions. The primers and PCR conditions used to amplify specific molecular markers are listed
in Table S1 (Supplementary Materials). The taxonomic position of sterile mycelia (lacking any
reproductive structures) presenting low homology with sequences available in public databases
was inferred by phylogenetic analysis; for the genus Emericellopsis, datasets based on sequences from
ribosomal internal transcribed spacer region (ITS) and partial beta-tubulin gene (TUB) were created
(Table S2, Supplementary Materials). Multiple alignments of each gene region were generated using
MUSCLE (default conditions for gap openings and gap extension penalties), implemented in MEGA v.
7.0 (Molecular Evolutionary Genetics Analysis), visually inspected, and manually refined to discard
ambiguously aligned regions. Then, alignments were concatenated into a single data matrix with
SequenceMatrix v. 1.8 [24]. The appropriate evolutionary model under the Akaike information criterion
(AIC) was determined with jModelTest 2 [25]. Bayesian inference (BI) was performed with MrBayes
3.2.2 [26] under a General Time Reversible with a proportion of Invariable sites plus discrete Gamma
evolutionary model (GTR + I + G; best model). The alignment was run for 10 million generations with
two independent runs, each containing four Markov chain Monte Carlo (MCMC) models and sampling
every 1000 iterations. The first 2500 trees were discarded as “burn-in” (25%). Using the Sumt function
of MrBayes, a consensus tree was generated and Bayesian posterior probabilities (BPP) were estimated.
Fungal strains were deposited at the Mycotheca Universitatis Taurinensis (MUT) collection
at the University of Turin. Sequences were registered in the GenBank database (Table S3,
Supplementary Materials).
2.3. Small-Scale Fermentation and OSMAC Approach
2.3.1. Multiwell Culture and Co-Culture Conditions
The isolated fungi were screened for the production of secondary metabolites by applying the
OSMAC approach, with the exception of Tetracladium sp. that did not grow in axenic culture. Fungi
were pre-grown in Petri dishes (9 cm Ø) containing Wickerham’s medium (WH; yeast extract 3 g, malt
extract 3 g, peptone 5 g, glucose 10 g, agar 15 g, Sigma-Aldrich, Saint Louis, USA, up to 1 L of DI H2O,
pH adjusted to 7.2–7.4) and incubated in the dark at 24 ◦C for seven days.
Mar. Drugs 2019, 17, 220 4 of 23
Subsequently, 24 multiwell plates were prepared with 1.5 mL/well of the following solid media:
WH, WHS (WH added with 3% NaCl), Potato Dextrose Agar (PDA; potato extract 4 g, dextrose 20 g, agar
15 g, up to 1 L DI H2O) PDAS (PDA added with 3% NaCl), Gelatin Agar (GA; gelatin 20 g, agar 15 g,
up to 1 L DI H2O), and GAS (GA added with 3% NaCl). Four replicates for each medium were set up.
Two cultural lines were set: (1) pure fungal cultures of the tested strains were inoculated into the
multiwell plates by placing 4 mm Ø mycelium discs (from the margin of actively growing colonies)
in the center of each well; (2) co-culture lines were prepared by inoculating a smear of Streptomyces sp.
MUT 2498 on the opposite side of the pure fungal culture discs. This bacterial strain, previously isolated
from the Atlantic sponge Dysidea fragilis, was chosen due to its ability to grow in all the tested conditions.
Inoculated multiwell plates were incubated in the dark at 24 ◦C for two weeks. The production of
exudates (e), soluble pigments (s), and production of conidia (h) were recorded. Fungal growth was
classified as follows: no growth (−), development of the fungal mycelium only on the inoculum disc
(+), mycelium covering of the area of the well (++), and fungal mycelium covering the entire surface of
the well (++).
Interactions with Streptomyces sp. MUT 2498 were determined as antagonism (a) where the
growth of the fungus stopped at a distance from the bacterial colony, predominance (p) where the
fungus grew on the bacterium, and no growth of the bacterium (n) [27].
2.3.2. Extraction Procedure and Chemical Analyses
For each well, the fungal biomasses and their associated media were freeze-dried. Dried samples
were suspended in 50 mL of MeOH:CH2Cl2 (1:1, v/v) and homogenized with an Ultra turrax IKA
device. The samples were then extracted three times by sonication with 50 mL of MeOH:CH2Cl2 (1:1,
v/v) and filtered. The combined filtrates were evaporated under reduced pressure.
In order to obtain the chemical fingerprint of each fungus (tested under different conditions), the
crude extracts were re-suspended in a mixture of MeOH:CH2Cl2 (1:1, v/v) to reach a final concentration
of 10 mg/mL. HPLC analyses were performed with a Waters Alliance 2695 HPLC system (Waters
Corporation, Milford, MA) coupled with a Waters 996 photodiode array detector, using a Macherey-Nagel
NUCLEODUR® Sphinx column (250× 4.6 mm, 5 µm). The mobile phase was composed of H2O (plus
0.1% HCO2H) and acetonitrile (CH3CN; plus 0.1% HCO2H), with the following gradient: H2O:CH3CN
90:10 to 0:100 for 30 min, 0:100 for 5 min, and 0:100 to 90:10 for 15 min.
Change in chemical diversity was evaluated on the basis of the presence of absorbance peaks at
a selected wavelength (280 nm) between 5 and 35 min of retention time. The following classes were
attributed: 0–3 peaks (class 1), 4–7 peaks (class 2), 8–11 peaks (class 3), and ≥12 peaks (class 4).
2.4. Scale-Up of Eurotium chevalieri MUT 2316
The test performed in multiwell plates recognized the fungus E. chevalieri MUT 2316 on PDAS as
the richest in secondary metabolites. Therefore, this strain was selected for further studies; both solid
and liquid culture conditions were assessed.
2.4.1. Solid Media Culture Condition and Secondary Metabolite Extraction from Eurotium chevalieri
MUT 2316
E. chevalieri MUT 2316 was pre-grown on PDA, and mycelium discs (4 mm Ø) were taken from
the margin of actively growing colonies to inoculate onto 200 Petri dishes (6 cm Ø) with PDAS. Plates
were incubated for two weeks at 24 ◦C. Petri dishes were then lyophilized to obtain 88 g of freeze-dried
material. The sample was suspended in a mixture of MeOH:CH2Cl2 (1:1, v/v) and homogenized
with an Ultra turrax IKA device. Secondary metabolites were firstly extracted 10 times with 2.5 L of
EtOAc:CH2Cl2 (1:1, v/v) and the fungal biomass was filtered under reduced pressure. The second
extraction was performed (12 times) with 3 L (total) of MeOH:CH2Cl2 (1:1, v/v) and the sample was
filtered under vacuum. The two organic filtrates were evaporated under reduced pressure to yield
orange-red organic extracts for both EtOAc:CH2Cl2 (1.9 g) and MeOH:CH2Cl2 (4.6 g) fractions.
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The EtOAc:CH2Cl2 organic fraction was further processed and fractionated by RP-C18 flash
chromatography (elution with a decreasing polarity gradient of H2O/MeOH from 1:0 to 0:1,
then MeOH/CH2Cl2 from 1:0 to 0:1). The first MeOH fraction (1.1 g), which was the richest in
secondary metabolites, was further purified by semi-preparative normal-phase HPLC (Lichrosorb Diol,
250× 10 mm, 5 µm, gradient: cyclohexane (Cy):EtOAc 90:10 to 0:100 for 30 min, 0:100 for 5 min, 0:100 to
and 90:10 for 10 min, with a flow rate of 3 mL/min) to afford pure echinulin (1) (3.2 mg), neoechinulin
A (2) (3.3 mg), dihydroauroglaucin (4) (4.3 mg), flavoglaucin (5) (11.2 mg), isodihydroauroglaucin (6)
(1.5 mg), and neoechinulin D (7) (1.5 mg).
In order to increase the yield of the fractions/compounds obtained, the original MeOH fraction
was subsequently fractionated by diol silica gel chromatography with a gradient from 100% Cy to
100% EtOAc, to afford physcion (3) (9.0 mg) and several fractions. Two fractions were further purified
by semi-preparative reversed-phase HPLC (Macherey-Nagel NUCLEODUR®Sphinx RP, 250 × 10 mm,
5 µm, gradient H2O/CH3CN plus 0.1% HCO2H 90:10 to 0:100 for 30 min, 0:100 for 5 min, and 0:100 to
90:10 for 10 min, with a flow rate of 3 mL/min) to afford pure echinulin (1) (6.4 mg), neoechinulin A
(2) (2.9 mg), dihydroauroglaucin (4) (7.7 mg), and flavoglaucin (5) (16.8 mg).
Structures of the isolated metabolites were elucidated through extensive MS and NMR spectral
analyses (Figures S1–S14, Supplementary Materials), as well as comparison of their spectral data to
those reported in the literature [20,28].
Stock solutions of the compounds were prepared at a concentration of 10 mg/mL (1 mg/mL for
(3)) in dimethyl sulfoxide (DMSO) for the bioassays.
2.4.2. Liquid Media Culture Condition and Secondary Metabolite Extraction from Eurotium chevalieri
MUT 2316
Ten agar plugs of E. chevalieri MUT 2316 were used to inoculate 20 Erlenmeyer flasks containing
180 mL of Potato Dextrose Broth (PDB; potato extract 4 g, dextrose 20 g, Sigma-Aldrich, Saint Louis,
USA, up to 1 L DI H2O), supplemented with 3% NaCl. Flasks were incubated for 14 days in the dark at
24 ◦C and 120 rpm. Cultures were filtered to separate the fungal biomass from the broth. The biomass
was freeze-dried and extracted as mentioned above for the solid extraction of E. chevalieri. Briefly, 1 L
of EtOAc:CH2Cl2 (1:1 v/v) and 1.5 L of MeOH:CH2Cl2 (1:1 v/v) were used to obtain, after evaporation
under reduced pressure, 2.4 g and 2.2 g of reddish organic extracts, respectively.
The broth was extracted with 6 L of EtOAc, and the resulting EtOAc solution was evaporated
under reduced pressure to give 0.8 g of a yellow-orange organic extract. The remaining aqueous fraction
was fractionated by RP-C18 silica gel column and eluted with MeOH to yield, once evaporated, 2.1 g
of a red-brown organic extract.
The EtOAc fraction was purified by semi-preparative reversed-phase HPLC (Macherey-Nagel
NUCLEODUR® Sphinx RP, 250 × 10 mm, 5 µm, gradient H2O/CH3CN (plus 0.1% HCO2H) 80:20
to 50:50 for 30 min, 0:100 for 5 min, and 0:100 to 80:20 for 10 min, with a flow rate of 3 mL/min)
to afford pure asperflavin (8) (1.0 mg), cinnalutein (9) (1.8 mg), and cyclo-L-Trp-L-Ala (10) (2.8 mg)
(Figures S15–S20, Supplementary Materials).
Stock solutions of the compounds were prepared at 10 mg/mL in DMSO for the bioassays.
2.5. High-Resolution Mass Spectrometry Analysis and Molecular Networking Analyses
High-resolution tandem mass spectrometry (HR-MS/MS) was carried out using a Finnigan LTQ
Orbitrap coupled to a Surveyor Plus HPLC pump and autosampler (Thermo Fisher, Bremen, Germany)
in positive ionization mode using an MS range of m/z 100–2000, an MS2 range of m/z 200–1500,
and an MSn range of m/z 0–1000, with 30,000 resolution. LC-MS data were acquired using Xcalibur
version 2.2. HR-MS/MS raw data files were converted from .RAW to .mzXML format using the
Trans-Proteomic pipeline (Institute for Systems biology, Seattle) [29], and clustered with MS-Cluster
using Global Natural Products Social Molecular Networking (GNPS-https://gnps.ucsd.edu) [30].
A molecular network was created using the online workflow at GNPS. The following settings were
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used for generation of the network: minimum pairs cos 0.6; parent mass tolerance, 1.0 Da; ion tolerance,
0.2; network topK, 10; minimum matched peaks, 6; minimum cluster size, 2. Data were visualized and
analyzed using Cytoscape 3.6.0.
The compounds common to both liquid and solid growth conditions of E. chevalieri MUT 2316
were highlighted, as well as the compounds unique to each condition.
2.6. Antiviral Assays
2.6.1. Cells and Viruses
African green monkey kidney cells (VERO, ATCC-American Type Culture Collection CCL-81)
and Madin Darby Canine Kidney cells (MDCK, ATCC® CRL-2936™) were propagated in Dulbecco’s
modified Eagle medium (DMEM; Euroclone), supplemented with 10% fetal bovine serum (FBS; Euroclone),
2 mM L-glutamine, 1 mM sodium pyruvate, 100 U/mL penicillin, and 100 µg/mL streptomycin sulfate.
Acyclovir-sensitive herpes simplex virus 1 (HSV-1) clinical isolate (kindly provided by V. Ghisetti,
Amedeo di Savoia Hospital, Turin, Italy) was propagated and titrated by plaque assay on VERO
cells as described previously [31]. The influenza A virus strain A/Puerto Rico/8/34 (IAV) was a
generous gift from Arianna Loregian (University of Padua, Italy), and was propagated and titrated
by plaque assay on MDCK cells. Infections with IAV were performed in the presence of 2 µg/mL
TosylPhenylalanylChloromethylKetone -treated trypsin from bovine pancreas (Sigma-Aldrich, Saint
Louis, USA) and 0.14% bovine serum albumin (BSA) (Sigma-Aldrich, Saint Louis, USA) in serum-free
complete medium [32].
2.6.2. Cytotoxicity Assays
To determine cell viability, confluent MDCK or VERO cells were seeded in 96-multiwell plates and
exposed to increasing concentrations of the compounds (12.5 µg/mL, 25.0 µg/mL, or 50.0 µg/mL), with
the exception of physcion (3), for which lower concentrations (6.25 µg/mL, 12.5 µg/mL, 25.0 µg/mL)
were used to avoid DMSO toxicity. The plates were incubated for 48 h at 37 ◦C, and then 100 µL of
CellTiter-Glo reagent (Promega) was added to lyse the cells and to determine cell viability according
to the producer’s instructions. The compounds were assessed for their antiviral activity at the
concentrations that produced at least 70% cell viability.
2.6.3. Plaque Reduction Assay
For plaque reduction assays (PRA) with IAV and HSV-1 viruses, MDCK and VERO cells were
seeded in 24-well plates at a density of 3 × 105 or 6 × 104 cells per well, respectively. The next day,
cultures were treated with the selected compounds at different concentrations 1 h prior to infection,
and then infected with 35 plaque-forming units (PFU)/well of either HSV-1 or IAV in the presence
of the compounds. Following virus adsorption (1 h at 37 ◦C for IAV or 2 h at 37 ◦C for HSV-1),
cultures were maintained in medium containing the corresponding compounds, supplemented with
0.14% BSA, 2 µg/mL trypsin, and 0.7% Avicel for IAV, or with 3% FBS and 0.9% Avicel for HSV-1.
All compounds’ concentrations were tested in duplicate in two independent experiments. Control
wells with mock-infected cells and untreated virus-infected cells were included in each plate. At 48 h
post-infection (p.i.), cell monolayers were fixed with 4% formaldehyde for 1 h at room temperature (RT)
and stained with a solution of 1% crystal violet for 40 min, before viral plaques were microscopically
counted. The mean plaque counts for each compound were expressed as a percentage of the mean
plaque count for the control virus.
2.7. Antibacterial Assays
2.7.1. Bacterial Growth Conditions
Representatives of Gram-positive and Gram-negative bacteria were selected for the antimicrobial
susceptibility tests. Three Gram-positive reference strains (Staphylococcus aureus ATCC 29213,
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Streptococcus pneumoniae ATCC 49619, and Enterococcus faecalis ATCC 29212) and two Gram-negative
reference strains (Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853) were used.
Furthermore, antibacterial activity of the isolated compounds was also assessed against recently
isolated clinical strains, selected and characterized as resistant or multidrug-resistant (MDR), from the
MicroMiB collection owned and maintained by the Laboratory of Clinical Microbiology and Virology
of the University of Milano-Bicocca, Monza, Italy: a methicillin-resistant Staphylococcus aureus (MRSA)
Monza-PFI, a fluoroquinolone-resistant S. aureus Monza-FD1, and a macrolide-resistant S. pneumoniae
Monza-82. MDR strains are conventionally defined as strains that are resistant against antibiotics
representative of at least three different antibiotic classes.
The strains, stored at −80 ◦C, were inoculated in fresh cation-adjusted Mueller–Hinton Broth
(CAMHB; acid digest of casein 17.5 g, soluble starch 1.5 g, beef extract 2 g, Sigma-Aldrich, Saint Louis,
USA, up to 1 L of DI H2O) and incubated overnight at 37 ◦C. S. pneumoniae Monza-82 was inoculated
in fresh Brain Heart Infusion broth (BHI; heart infusion 5 g, calf brains 12.5 g, Na2HPO4 2.5 g,
D(+)-glucose 2 g, peptone 10 g, NaCl 5 g, Sigma-Aldrich, Saint Louis, USA, up to 1 L of DI H2O) with
the addition of 5% defibrinated sheep blood and incubated overnight at 37 ◦C in 5% CO2 atmosphere
for optimal growth.
2.7.2. Minimal Inhibitory Concentration (MIC) Determination
MICs were determined following Clinical and Laboratory Standards Institute (CLSI) guidelines
for the broth microdilution method [33]. Briefly, two-fold serial dilutions of the stock solutions of the
tested compounds and antibiotic were prepared in cation-adjusted Mueller–Hinton Broth (CAMHB)
or CAMHB + 5% defibrinated sheep blood (for S. pneumoniae) in 96-multiwell microtiter plates; the
bacterial inoculum adjusted to 1 × 106 colony-forming units (CFU)/mL was equally added to the
wells to reach a final concentration of 5 × 105 CFU/mL. Gentamicin, ciprofloxacin, tetracycline,
erythromycin, and fusidic acid (Sigma-Aldrich, Saint Louis, USA) were used as reference antibiotics.
The plates were incubated at 37 ◦C for 18–24 h. After the incubation, each well was checked for the
absence of bacterial pellets and the clearness of the solution; then, the MIC value (µg/mL), defined as the
lowest concentration of antimicrobial agent causing visible inhibition of bacterial growth, was determined.
All the tested compounds, except for antibiotics, were solubilized in 100% DMSO (stock solutions)
and appropriate dilutions were set up to prevent solvent toxicity. Positive strain controls without the
antimicrobial compounds, controls with DMSO, and non-inoculated media were run in parallel with
the tested compounds as internal controls.
2.7.3. Minimal Bactericidal Concentration (MBC) Determination
The MBC was determined after the MIC assays; briefly, once the MIC was determined, the content
of those wells and the wells with 2× MIC and 4× MIC concentration were plated on Tryptic Soy
Agar (TSA; pancreatic digest of casein 15 g, peptic digest of soybean meal 5 g, NaCl 5 g, agar 15 g,
Sigma-Aldrich, Saint Louis, USA, up to 1 L of DI H2O) or Mueller–Hinton Fastidius Agar (MHF; meat
extract 2 g, acid hydrolysate of casein 17.5 g, starch 1.5 g, agar 17 g, horse blood mechanically defibrinated
5%, β-NAD 0.02 g) for the Streptococcus strains. Plates were incubated at 37 ◦C in aerobic conditions or
in 5% CO2 atmosphere and checked for bacterial growth after 24 h. The MBC values, defined as the
lowest concentration of antimicrobial agent needed to kill bacteria, were determined by evaluating the
minimal concentration at which an absence of bacterial growth in the agar plates was detected.
3. Results and Discussion
3.1. The Mycobiota of Grantia compressa
The culturable mycobiota associated with G. compressa were evaluated for the first time in this
study. Twenty-one strains ascribable to 17 taxa were detected (Table 1).
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Table 1. Fungal taxa isolated from Grantia compressa with the percentage relative abundance (RA) of recovery and the isolation conditions (isolation methods, media,
and temperature). The species already found in the marine environment (MA) and associated with sponges (SP) are reported, as well as the first record (FR).
MUT
CODE
Taxa RA (%)
Isolation
Method Isolation Media
Incubation
Temperature Report
DP HO CMASW GASW MEA SWA 15 ◦C 25 ◦C MA SP
2282
Coprinellus sp. * 8.7
x x x
- -
2332 x x x
2288 Ceriporia lacerate * 4.3 x x x [34,35] FR
2307
Cladosporium allicinum 13.0
x x x
[16,36] [18]
2313 x x x
2314 Cladosporium cladosporioides 4.3 x x x [15,16,36–42] [18,43–48]
2315 Cladosporiumpseudocladosporioides 8.7 x x x [16,38] [18]
2273
Emericellopsis pallida * 8.7
x x x
[15] [18]
2274 x x x
2316 Eurotium chevalieri 4.3 x x x [15,40,42,49,50] [47]
2334 Euthypella scoparia * 4.3 x x x [51] [8]
2317 Fusarium solani 4.3 x x x [52,53] [54,55]
2321 Penicillium chrysogenum 4.3 x x x [15,38,39,42] [47,54,56,57]
2328 Penicillium oxalicum 4.3 x x x [15,42,53,58–60] [61]
2322
Penicillium paneum 8.7
x x x
[15,62] FR
2326 x x x
2331 Psathyrella candolleana * 4.3 x x x FR FR
2415 Rhodotorula mucilaginosa 4.3 x x x [15,63,64] FR
- Tetracladium sp. * 4.3 x x x - -
2410
Tolypocladium cylindrosporum 8.7
x x x
[39,53,65] [18]
2413 x x x
* Sterile mycelium. DP—direct plating; HO—homogenization; CMASW—Corn Meal Agar sea water; GASW—Gelatin Agar sea water; MEA—Malt Extract Agar; SWA—Sea Water Agar.
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The use of two isolation techniques, four media, and two incubation temperatures facilitated an
increase in the number of cultivable fungi, considering that 70% of the fungi were found in just one of
the tested conditions (Table 1).
Overall, the mycobiota of G. compressa were composed of Ascomycota (77.8%) and Basidiomycota
(22.2%). The dominance of Ascomycota is confirmed in many marine environments [14,53]. The high
percentage of Basidiomycota is surprising given that several studies indicated the low abundance of
Basidiomycota in sponges (lower than 10% [18,54,66,67] or null [47,56,68–71]).
A low rank identification of taxa is essential for the de-replication process useful for the discovery
of new compounds [72,73]. By means of a polyphasic approach, 86% of taxa were identified at
species level and 14% at genus level. A high percentage of taxa (41%) remained sterile in axenic
culture; this is not unusual for marine fungi [47,53,68]. Sterile mycelia included five Basidiomycota
that were identified by Poli et al. [74], while the doubtful systematic position of two Ascomycota,
namely MUT 2273 and MUT 2274, was clarified by systematic analysis and they were identified as
Emericellopsis pallida (Figure S21, Supplementary Materials).
Overall, while Ceriporia lacerata, Penicillium paneum, and Rhodotorula mucilaginosa are reported here
for the first time in association with marine sponges, for Psathyrella candolleana, it is the first report from
the marine environment. Interestingly, Zhao et al. [34] found a strain of C. lacerata, capable of producing
novel secondary metabolites, in association with another marine invertebrate, the crown-of-thorns
starfish Acanthaster planci.
G. compressa, was sampled along the Irish coast with three additional sponges (Dysidea fragilis,
Pachymatisma johnstonia, and Sycon ciliatum) that possessed four common fungal species in their
mycobiota [18]. Intriguingly, three out of the four fungal species, namely Cladosporium allicinum,
C. cladosporioides, and Tolypocladium cylindrosporum, were also isolated from G. compressa, supporting
the hypothesis that fungal species retrieved from different sponge species may belong to a transient
mycobiota, probably not strictly associated with the animals [67]. Compared to the three other sponges
mentioned above, G. compressa hosted the lowest fungal diversity. However, the taxa recorded (17)
are in line with other studies on sponge-associated mycobiota: for instance, 19 fungal genotypes were
identified in the Atlantic sponge Haliclona simulans [75], and a pool of several sponge species allowed
the description of about 20 fungal taxa [43,48]. Several factors, such as isolation techniques, sponge
tissue structure, and the ability of the sponge to produce metabolites, may influence the number of
fungal taxa retrieved [47]. Concerning the capability of G. compressa to select the fungal community by
producing particular substances, there are no reports about the metabolome of this sponge. However,
since also the bacterial diversity (12 strains) was particularly low, as previously reported [76], this
sponge might be able to control its microbial load.
3.2. OSMAC Approach
3.2.1. Effect of Media on Fungal Development and Chemical Fingerprint
Multiwell assays to test different growth conditions are considered a valuable method for the
screening of marine-derived fungi as producers of interesting metabolites [8,77]. The optimal growth
of fungi was the first parameter that was taken into account; indeed, in light of industrial exploitation
for secondary metabolite production, a fast-growing fungus must be preferred. Among the culture
media tested, WH medium supported fungal growth of all the strains; after 14 days, all fungi occupied
the entire medium surface (Figure 1a). PDA also supported the fungal growth and 95% of the fungi
covered the entire medium surface (Figure 1a). These results are in line with a previous work that
demonstrated that two weeks are necessary for slow-growing species to cover the entire surface of a
24-well plate [78]. From a chemical point of view, nutrient-rich media better induce metabolic diversity
(Figure 1b). Indeed, classes 3 and 4 (high metabolic production), accounted for 10% and 20% of the
tested strains on PDA and WH, respectively. On the contrary, the low-nutrient gelatin-based medium
(GA) did not support proper fungal growth; only 50% of fungi occupied the entire well on GA after
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two weeks (Figure 1a). This affected the metabolic diversity that was strongly reduced and ascribable
only to classes 1 and 2 (Figure 1b).
The OSMAC approach was proven to be a powerful method. In fact, each of the tested fungi
showed different metabolic classes in at least one of the three media tested, thus underlining the
best conditions for the stimulation of secondary metabolites (Table S4, Supplementary Materials).
The only exceptions were represented by C. allicinum MUT 2307 and C. cladosporioides MUT 2315,
showing the same metabolic class (2) in all three conditions, although the occurrence of exclusive
peaks characterized both WH and PDA (Table S4, Supplementary Materials).
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Figure 1. (a) Fungal growth on three media, classified as development of the fungus on the inoculum
(+), occupation of half the area of the well (++), or complete growth of the fungus on all the surface of
the well (+++). (b) Change in the chemical diversity of fungal extracts due to the different conditions
assessed. Classification based on the number of HPLC ultraviolet (UV) 280-nm peaks: 0–3 peaks
(class 1), 4–7 peaks (class 2), 8–11 peaks (class 3), and ≥12 peaks (class 4).
3.2.2. Effect of Salt on Fungal Development and Chemical Fingerprint
The presence of salt did not affect the number of secondary metabolites detected for most fungi
under different conditions (Figure 2). The metabolism of the re aining fungi was mostly inhibited
by the presence of salt (Figure 2), i.e., on WHS, for three out of five Basidiomycota, namely C. lacerata
MUT 2288, Coprinellus sp. MUT 2332, and P. candolleana MUT 2331 (Tables S4 and S5, Supplementary
aterials), the production of secondary metabolites and the growth rate decreased in the presence of
salt. On the contrary, a small number of fungi produced more metabolites in the presence of salt, i.e.,
Penicillium chrysogenum MUT 2321 on both PDAS and WHS (Table S4, Supplementary Materials).
Overall, the different abilities of fungi to tolerate salt could be related to their position within
sponges. Endophytic fungi, not exposed to osmotic pressure, were already detected within sponges [79]
and, consequently, some of the isolated fungi found within sponge tissues could be negatively affected
by the presence of salt. Certainly, salt can be a stress factor for endophytes, and it can also mimic
environmental conditions for sponge-associated fungi more exposed to seawater, modulating their
etabolic production as already demonstrated [80–82].
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Figure 2. Percentage of fungal strains in which the presence of salt increased, decreased, or did not
infl ence the metabolic diversity (same metabolic classes), related to the different conditi ns tested
(thre m dia in pure and co-culture).
3.2.3. Effect of Co-Culture on Fungal Development and Chemical Fingerprint
The co-culture differentially influenced fungal growth (Table S5, Supplementary Materials)
possibly due to space and nutrient competition that generally occur in dual culture [83]. On PDAS,
25% of the fungi completely inhibited the bacterium (Figure 3); this was probably due to the slow
bacterial growth on this medium compared to the other media. Overall, on WH, WHS, PDA, and
PDAS, 75%, 60%, 60%, and 35% of the fungi, respectively, interacted with the bacterium with an
antagonistic response or over-growing it (Figure 3). When an antagonistic response (a) or dominance
of the fungus (p) was observed, the metabolic production respectively increased in 15% and 16%
of the cases (Tables S4 and S5, Supplementary Materials). Noteworthy, even when the number of
metabolites was constant or decreased, exclusive peaks were found in one-third of the fungi; this was
the case of E. pallida MUT 2273 that clearly showed an antagonistic response against the bacterium
on WH and PDA and produced exclusive peaks not detected in other conditions (Tables S4 and S5,
Supplementary Materials). The presence of exclusive peaks in co-culture represents direct evidence of
the interaction on a specific medium between the two organisms tested; however, whether the fungus
or the bacterium is responsible for the production of the compounds was difficult to determine.
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Figure 3. Percentage of fungi interacting in different ways with the bacterium. Interactions are
classified as antagonism (a), predominance (p), and total inhibition of the bacterial growth (n) on the
six tested media.
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3.2.4. General Remarks on the OSMAC Approach
Considering the 12 conditions tested, it was clear that some fungi presented a reduced metabolic
diversity, which was not particularly influenced by growth conditions. This was the case for C. lacerata
MUT 2288, Coprinellus sp. MUT 2282, and Euthypella scoparia MUT 2334 (Table S4, Supplementary
Materials). On the contrary, E. chevalieri MUT 2316 produced more metabolites than any other tested
fungi, in particular on all nutrient-rich media in pure culture and in co-culture (Figure 4).
Moreover, the production of secondary metabolites appeared to be specific for each strain (Table S4,
Supplementary Materials). This was very evident for T. cylindrosporum (MUT 2410 and MUT 2413)
and E. pallida (MUT 2273 and MUT 2274), while it was not for C. allicinum (MUT 2307 and MUT 2313),
P. paneum (MUT 2322 and MUT 2326), and Coprinellus sp. (MUT 2282 and MUT 2332).
Overall, the OSMAC approach is a valuable method for the induction of different secondary
metabolites [8]. Several fungi showed enhanced metabolic production/diversity, together with a
clear morphological variation. This might be useful for a first screening of the most promising
culture condition; usually, when clear morphological variations are observed, the fungus produces
different metabolites.
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3.3. Eurotium chevalieri MUT 2316: Molecular Networking and Compounds
E. chevalieri MUT 2316 produced a higher number of and more chemically diverse metabolites in
comparison to the other fungi tested. For this reason, E. chevalieri MUT 2316 was selected for scale-up
and metabolite identification. The medium that supported better growth and chemical diversity of the
fungus was the medium PDAS. Both solid and liquid culture conditions were tested for the scale-up of
E. chevalieri MUT 2316.
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The growth of E. chevalieri in solid medium yielded 628 parent ions, half of which were common
to the same fungus grown in liquid media, which yielded 536 compounds.
The purification process of the crude organic extracts from the solid and liquid cultures yielded
10 compounds (Figure 5): echinulin (1), neoechinulin A (2), physcion (3), dihydroauroglaucin (4),
flavoglaucin (5), isodihydroauroglaucin (6), neoechinulin D (7), asperflavin (8), cinnalutein (9), and
cyclo-L-Trp-L-Ala (10).
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The graphical representation of the molecular network allowed underlining in which condition
(solid/liquid) the pure compounds isolated in this study were produced. Figure 6 shows the molecular
clusters where the compounds were found; green, blue, and fuchsia nodes indicate compounds found
in solid media, liquid media, and in both conditions, respectively. Nine compounds were produced in
both solid and liquid culture conditions, while 7 was produced only in the solid medium. Moreover,
the presence of different compounds in the same cluster underlined a common biosynthetic pathway;
this was the case for 1 and 7, as well as for 4, 5, and 6.
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3.4. Eurotium chevalieri-Derived Compounds Show Antiviral Activity against Herpes and Influenza Viruses
To evaluate the antiviral activity of the metabolites (1–10) isolated from E. chevalieri MUT 2316, we
investigated their effects on the replication of IAV and a clinical isolate of HSV-1. Prior to the assessment
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of the antiviral activity by PRA, cell viability assays were performed to exclude non-specific cell
toxicity of the tested compounds against MDCK and VERO cells. To this end, different concentrations
of each compound were tested, and compounds were considered not toxic only if they produced
at least 70% cell viability after 48 h of treatment. Based on this parameter, flavoglaucin (5) and
isodihydroauroglaucin (6), even at the lowest dose (12.5 µg/mL), were considered toxic for MDCK cells,
whereas only flavoglaucin (5) was considered toxic for VERO cells (50% cytotoxic concentration (CC50)
for both compounds <12.5 µg/mL). Thus, flavoglaucin (5) and isodihydroauroglaucin (6) were not
further investigated for their antiviral activity against IAV, while flavoglaucin (5) was not tested against
HSV-1. Based on results obtained from the cytotoxicity assay for IAV, echinulin (1) and neoechinulin D
(7) were tested at concentration of 50 µg/mL, neoechinulin A (2), physcion (3), dihydroauroglaucin (4),
and cyclo-L-Trp-L-Ala (10) were tested at 25 µg/mL, and asperflavin (8) and cinnalutein (9) were tested
at 12.5 µg/mL. For HSV-1, echinulin (1), neoechinulin A (2), cyclo-L-Trp-L-Ala (10), neoechinulin D
(7), and asperflavin (8) were examined at 50 µg/mL, physcion (3) and dihydroauroglaucin (4) were
examined at 25 µg/mL, and isodihydroauroglaucin (6) and cinnalutein (9) were examined at 12.5
µg/mL. Among the compounds tested, dihydroauroglaucin (4), physcion (3), and neoechinulin D
(7) inhibited the replication of IAV by 100%, 80%, and 70%, respectively (Figure 7a); the antiviral
activity against IAV was observed for the first time for five out of eight compounds, while echinulin (1),
neoechinulin A (2), and cyclo-L-Trp-L-Ala (10) were already tested against another strain of Influenza
(A/WSN/33) by Chen et al. [84]. For HSV-1 replication (Figure 7b), total inhibition (100%) was
observed for the first time for both physcion (3) and neoechinulin D (7). Activity against HSV-1 was
previously assessed only for isodihydroauroglaucin (6) [28].
Overall, these results suggest significant antiviral activities for some secondary metabolites
from E. chevalieri, such as physcion (3), dihydroauroglaucin (4), and neoechinulin D (7), against two
important human viral pathogens. These data indicate that the antiviral potential of these compounds
deserves further analyses. In this regard, a detailed analysis of their mechanism of action against both
IAV and HSV is underway.
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Figure 7. Effect of the compounds derived from E. chevalieri on (a) influenza A virus (IAV) and
(b) herpes simplex virus 1 (HSV-1) replication. The mean plaque counts for each molecule are expressed
as a percentage of the mean plaque count of the control. The data shown are the means ± standard
deviations (SD) from two independent experiments performed in duplicate.
3.5. Eurotium chevalieri-Derived Compounds Show Antibacterial Activity
All the metabolites (1–10) were evaluated for their antibacterial activity against reference strains of
Gram-positive and Gram-negative bacteria, as well as on selected clinical isolates of multidrug-resistant
bacteria. Table 2 reports the MIC and MBC values of each compound. Isodihydroauroglaucin (6) was
the most promising with antibacterial activity on the majority of the Gram-positive bacteria tested
(except S. pneumonia ATCC 49619), with MIC values ranging from 4 µg/mL to 64 µg/mL; the lowest
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value was observed against the macrolide-resistant S. pneumoniae Monza-82. Isodihydroauroglaucin
(6) showed similar MIC values when tested against Bacillus cereus and Salmonella typhimurium [28].
Similar to isodihydroauroglaucin (6), dihydroauroglaucin (4) was active against the majority of
the Gram-positive bacteria (except for S. pneumonia ATCC 49619), with MIC values of 128 µg/mL,
64 µg/mL, and 8 µg/mL on S. aureus strains, E. faecalis, and S. pneumoniae, respectively. This compound
was previously considered inactive against reference and MRSA S. aureus strains, probably due to
the low concentration tested [85]. Here, we report for the first time the antibacterial activity of
dihydroauroglaucin (4).
Asperflavin (8) was active against all S. aureus strains and S. pneumoniae Monza-82, with MIC
values of 64 µg/mL and 32 µg/mL, respectively. Ganihigama et al. [86] reported the antibacterial
activity of asperflavin (8) against Mycobacterium tuberculosis (MIC 25 µg/mL).
This study represents the first assessment of the antibacterial activity of cinnalutein (9), showing
positive results against the fluoroquinolone-resistant S. aureus Monza-FD1 (MIC 128 µg/mL) and
macrolide-resistant S. pneumoniae Monza-82 (MIC 32 µg/mL).
Of note, S. pneumoniae Monza-82 showed sensitivity to all the compounds mentioned above,
including physcion (3) and neoechinulin D (7).
Physcion (3) was previously tested against Micrococcus luteus (MIC 200 µg/mL), Klebsiella pneumoniae
(MIC 250 µg/mL), and P. aeruginosa (MIC 200 µg/mL) [87]. On the contrary, Zin et al. [20] observed
no antibacterial activity for physcion (3). This highlights that the use of different bacterial strains can
significantly influence the results. The other compounds (Table 2) did not show antibacterial activity at
the concentrations tested (0.06–128 µg/mL for 1, 2, and 10; 0.015–32 µg/mL for 5), confirming previous
reports for cyclo-L-Trp-L-Ala (10) [88] and echinulin (1) [28,85,89,90].
Isodihydroauroglaucin (6) also showed bactericidal activity for most of the bacteria tested,
whereas dihydroauroglaucin (4) and asperflavin (8) showed positive results only against the
S. pneumoniae Monza-82 strain.
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Table 2. Minimum inhibitory concentration (MIC µg/mL) and minimum bactericidal concentration (MBC µg/mL) values of compounds (1–10) against reference
strains and multidrug-resistant isolates.
Bacteria Staphylococcus aureus Enterococcusfaecalis Streptococcus pneumoniae
Pseudomonas
aeruginosa Escherichia coli
Compounds
ATCC 29213 Monza-PFI Monza-FD1 ATCC 29212 ATCC 49619 Monza 82 ATCC 27853 ATCC 25922
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
Echinulin (1) >128 N/A >128 N/A >128 N/A >128 N/A >128 N/A >128 N/A >128 N/A >128 N/A
Neoechinulin A (2) >128 N/A >128 N/A >128 N/A >128 N/A >128 N/A >128 N/A >128 N/A >128 N/A
Physcion (3) >32 N/A >32 N/A >32 N/A >32 N/A >32 N/A 16 >32 >32 N/A >32 N/A
Dihydroauroglaucin (4) 128 >128 128 >128 128 >128 64 >128 >128 N/A 8 32 >128 N/A >128 N/A
Flavoglaucin (5) >32 N/A >32 N/A >32 N/A >32 N/A >32 N/A >32 N/A >32 N/A >32 N/A
Isodihydroauroglaucin (6) 64 128 64 128 32 64 64 >128 >128 N/A 4 16 >128 N/A >128 N/A
Neoechinulin D (7) >128 N/A >128 N/A >128 N/A >128 N/A >128 N/A 64 >128 >128 N/A >128 N/A
Asperflavin (8) 64 >128 128 >128 64 >128 >128 N/A >128 N/A 32 128 >128 N/A >128 N/A
Cinnalutein (9) >128 N/A >128 N/A 128 >128 >128 N/A >128 N/A 32 >128 >128 N/A >128 N/A
Cyclo-L-Trp-L-Ala (10) >128 N/A >128 N/A >128 N/A >128 N/A >128 N/A >128 N/A >128 N/A >128 N/A
Gentamicin 0.5 N/D >128 N/D 1 N/D >128 N/D N/D N/D N/D N/D 1 N/D 0.5 N/D
Ciprofloxacin 0.25 N/D 64 N/D 8 N/D 0.25 N/D 0.5 N/D 1 N/D 0.12 N/D ≤0.06 N/D
Erythromycin 0.5 N/D 8 N/D 0.5 N/D 2 N/D 0.12 N/D 16 N/D N/D N/D N/D N/D
Tetracycline 0.12 N/D 1 N/D 1 N/D 8 N/D 0.12 N/D ≤0.06 N/D 8 N/D 1 N/D
Fusidic acid 0.12 N/D N/D N/D N/D N/D 4 N/D 4 N/D N/D N/D N/D N/D N/D N/D
N/D, not done; N/A, not applicable.
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4. Conclusions
In conclusion, in this study, we highlighted the high biodiversity of marine-derived fungi
inhabiting the Atlantic sponge G. compressa, and the chemodiversity and biotechnological potential of
the fungal strain E. chevalieri MUT 2316. The OSMAC approach, applied to all the fungi retrieved in
G. compressa, was demonstrated to be a powerful method to stimulate the production of an incredible
variety of secondary metabolites.
E. chevalieri MUT 2316 produced the highest number of metabolites and among the compounds
isolated; dihydroauroglaucin (4), physcion (3), and neoechinulin D (7) completely inhibited viral
replication of IAV or HSV-1. Moreover, six compounds were active against Gram-positive bacteria; with
isodihydroauroglaucin (6) active against most of the Gram-positive bacteria tested (MIC 4-64 µg/mL)
with bactericidal activity.
Finally, the results obtained in the present work demonstrate that even already known compounds
can show new and promising biological activities.
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